COOPER COMPANIES Reports Q1 2023 Earnings Results on March 2nd

March 5, 2023

Earnings report

COOPER ($NYSE:COO): It has been clear that their efforts have paid off in the form of increased profits for the quarter, and it is expected that this trend will continue in the upcoming quarters of FY2023. The company is well on its way to achieving its goal of becoming an international leader in its field of business.

Price History

The company’s stock opened at $321.0 and closed at $327.9, a 1.3% increase from the previous closing price of $323.6. Although the increase was small, investors viewed the news positively, especially considering the fact that the stock had been volatile in recent weeks. Overall, the release of COOPER COMPANIES‘ earnings report for Q1 was positive news for shareholders and investors alike. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cooper Companies. More…

    Total Revenues Net Income Net Margin
    3.38k 375.1 10.4%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cooper Companies. More…

    Operations Investing Financing
    692.4 -1.83k 1.19k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cooper Companies. More…

    Total Assets Total Liabilities Book Value Per Share
    11.56k 4.23k 145.16
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cooper Companies are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    8.2% -0.1% 16.3%
    FCF Margin ROE ROA
    13.3% 4.8% 3.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we provide a comprehensive financial analysis of COOPER COMPANIES, helping you make an informed investment decision. We have analyzed the financials of COOPER COMPANIES and have assigned it a medium risk rating. This is based on the potential risks associated with its balance sheet, cash flow, income statement, and other financial data. We have also detected one risk warning in the company’s balance sheet that may be a red flag for potential investments. To find out more about this, be sure to register with us to access all of our resources. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • Peers

    The Cooper Companies Inc and its competitors, Sonova Holding AG, Pfizer Inc, and Teleflex Inc, compete in the global medical device market. Sonova Holding AG is a leading manufacturer of hearing aids and other auditory products. Pfizer Inc is a leading manufacturer of pharmaceuticals, vaccines, and other health care products. Teleflex Inc is a leading manufacturer of medical devices and other health care products.

    – Sonova Holding AG ($LTS:0QPY)

    Sonova Holding AG is a global leader in providing hearing care solutions. The company has a market capitalization of 15.4 billion as of 2022 and a return on equity of 21.26%. Sonova’s products are sold in over 100 countries and the company has a strong presence in Europe, North America, and Asia Pacific. The company’s products include hearing aids, cochlear implants, and wireless communication solutions.

    – Pfizer Inc ($NYSE:PFE)

    Pfizer Inc is a multinational pharmaceutical corporation. It is one of the world’s largest pharmaceutical companies. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhard. The company has its headquarters in New York City.

    Pfizer’s market cap is $270.73 billion as of 2022. Its return on equity is 27.98%. The company manufactures and sells a broad range of pharmaceutical products, including prescription and over-the-counter drugs. The company’s products are sold in more than 150 countries.

    – Teleflex Inc ($NYSE:TFX)

    Teleflex Inc is a medical device company that provides products and services for a variety of medical conditions. The company has a market cap of 10.2B as of 2022 and a Return on Equity of 8.5%. Teleflex Inc’s products and services include catheters, respiratory devices, and surgical instruments. The company serves patients, families, and healthcare professionals worldwide.

    Summary

    Cooper Companies reported an 11.2% decrease in total revenue for the quarter compared to the same period last year, coming in at USD 84.6 million. Despite this decrease, the company’s net income reported a 9.1% increase for the quarter, totaling USD 858.5 million. This indicates that the company’s cost-saving strategies have paid off, but investors should exercise caution as their revenue may be in decline. Nonetheless, Cooper Companies’ financials have been relatively strong and could indicate potential future growth.

    Recent Posts

    Leave a Comment